Office of Research & Development |
|
Project Number: | I01CX002006-01 |
Title: | A Phase 2 study of a Checkpoint Inhibitor in Men with Progressive Metastatic Castrate Resistant Prostate Cancer Characterized by a Mismatch Repair Deficiency or Biallelic CDK12 Inactivation (CHOMP) |
Principal Investigator: | Matthew B. Rettig |
Location: | West Los Angeles, CA |
Congressional District Code: | 33 |
Research Service: | Clinical Science R&D |
Project Period: | April 2020 - March 2024 |
FY 2024 Funding Amount: | $72,086 |
Abstract: |
View abstract and other project information on NIH RePORTER Go To NIH RePORTER |